Embolx

Sunnyvale, CA · Founded 2013 · Privately Held (backing)

Developer of medical devices designed for arterial embolization procedures. Embolx is based in Sunnyvale, CA and was founded in 2013. Its last reported valuation was $37.6 million in Jul 2021. It has raised $16.5 million across 3 recorded rounds; the latest was a $1.6 million seed round in Oct 2022.

Last reported valuation
$37.6M
Oct 2026
Priced at
—
Total raised
$16.5M
Last round
Seed Round
Oct 2022
How much has Embolx raised?
$16.5Macross 3 recorded rounds · Feb 2014 – Oct 2022

Most recently, Embolx raised $1.6M in its Seed Round (Oct 2022).

Free account
More of Embolx with a free account
  • ·The complete investor list: 14 names
  • ·Watch Embolx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Embolx round by round

3 rounds
Oct 2022Seed Round$1.6MSEC filing▮
5 investors participated
May 2014Seed Round$250KSEC filing▮
1 investors participated
Feb 2014Seed Round$250KSEC filing▮
1 investors participated

How much has Embolx raised?

Embolx has raised $16.5 million in total; 3 of its rounds are on record, from 2014 on. The largest on record was a $250,000 seed round in Feb 2014; the most recent was a $1.6 million seed round in Oct 2022.

Embolx has filed 5 Form Ds with the SEC since 2014, most recently in Nov 2022 ($1.6 million sold to 5 investors).

Embolx investors

14 investors are on record for Embolx, including US National Science Foundation, MedTech Innovator, Keiretsu Forum and Band of Angels. The seed round in Oct 2022 drew 5 investors.

For fundraisers
Raising for a company like Embolx?

14 investors have backed Embolx.

See all 14 investors →

Frequently asked about Embolx

How much has Embolx raised?
Embolx has raised $16.5M in total across 3 recorded funding rounds.
When was Embolx's last funding round?
Embolx's most recent recorded round was Seed Round in Oct 2022, raising $1.6M.